Reply: Is High-Dose Glucocorticoid Beneficial in Covid-19?

Reply: Is High-Dose Glucocorticoid Beneficial in Covid-19? Publisher Pubmed

Edalatifard M¹ ; Akhtari M^{2, 3} ; Salehi M⁴ ; Farhadi E^{2, 3} ; Jamshidi A² ; Mahmoudi M^{2, 3} ; Rostamian A⁵

Show Affiliations

1. Advanced Thoracic Research Center, Tehran University of Medical Sciences, Tehran, Iran
2. Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran
3. Inflammation Research Center, Tehran University of Medical Sciences, Tehran, Iran
4. Dept of Infectious and Tropical Medicines, Tehran University of Medical Sciences, Tehran, Iran
5. Rheumatology Research Center, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran

Source: European Respiratory Journal Published:2021

Abstract

[No abstract available]

2. Tocilizumab Failed to Reduce Mortality in Severe Covid-19 Patients: Results From a Randomized Controlled Clinical Trial, Iranian Journal of Allergy# Asthma and Immunology (2024)

3. Relapse of Covid-19-Associated Mucormycosis in Patients Receiving Posaconazole As Maintenance Treatment, Journal of Infection in Developing Countries (2024)

4. Comparison of Corticosteroids Types, Dexamethasone, and Methylprednisolone in Patients Hospitalized With Covid-19: A Systematic Review and Network Meta-Analysis, Global Epidemiology (2023)

Experts (# of related papers)

View all Related Experts

Hossein Khalili (1)

Kourosh Sadeghi (1)

Style	Citing Format
MLA	Edalatifard M, et al.. "Reply: Is High-Dose Glucocorticoid Beneficial in Covid-19?." European Respiratory Journal, vol. 57, no. 4, 2021, pp. -.
APA	Edalatifard M, Akhtari M, Salehi M, Farhadi E, Jamshidi A, Mahmoudi M, Rostamian A (2021). Reply: Is High-Dose Glucocorticoid Beneficial in Covid-19?. European Respiratory Journal, 57(4), -.
Chicago	Edalatifard M, Akhtari M, Salehi M, Farhadi E, Jamshidi A, Mahmoudi M, Rostamian A. "Reply: Is High-Dose Glucocorticoid Beneficial in Covid-19?." European Respiratory Journal 57, no. 4 (2021): -.
Harvard	Edalatifard M et al. (2021) 'Reply: Is High-Dose Glucocorticoid Beneficial in Covid-19?', European Respiratory Journal, 57(4), pp. -.
Vancouver	Edalatifard M, Akhtari M, Salehi M, Farhadi E, Jamshidi A, Mahmoudi M, et al.. Reply: Is High-Dose Glucocorticoid Beneficial in Covid-19?. European Respiratory Journal. 2021;57(4):-.
BibTex	@article{ author = {Edalatifard M and Akhtari M and Salehi M and Farhadi E and Jamshidi A and Mahmoudi M and Rostamian A}, title = {Reply: Is High-Dose Glucocorticoid Beneficial in Covid-19?}, journal = {European Respiratory Journal}, volume = {57}, number = {4}, pages = {-}, year = {2021} }
RIS	TY - JOUR AU - Edalatifard M AU - Akhtari M AU - Salehi M AU - Farhadi E AU - Jamshidi A AU - Mahmoudi M AU - Rostamian A TI - Reply: Is High-Dose Glucocorticoid Beneficial in Covid-19? JO - European Respiratory Journal VL - 57 IS - 4 SP - EP - PY - 2021 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract